International Conference on Clinical Drug Developments and Pharmacovigilance
Aims and Objectives:
|International Conference on Clinical Drug Developments and Pharmacovigilance|
|Place||Hong Kong, China|
The ICPPP 2017: 19th International Conference on Pharmacology, Parmacokinetics and armacovigilance a ims to bring together leading academic scientists, researchers and research scholars to exchange and share experiences and research results about all aspects of Pharmacology, Pharmacokinetics and Pharmacovigilance. It also provides the premier interdisciplinary forum for researchers, practitioner and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Pharmacology, Pharmacokinetics and Pharmacovigilance.
Call for Papers:
Bio-pharmaceutics and pharmaceutics Pharmacy practice Pharmaceuticals testing Pharmaceutical chemistry Pharmaceutical crops Pharmacology and antibiotics Drug discovery and development Protein-protein interactions as drug targets Adrenergic drugs Anesthesia pharmacology Application of membrane protein structure determination and its applications in drug design Chemotherapy and other anti-neoplastic drugs Clinical pharmacology and pharmacy Design and optimization of dosage regimens Drug development Drug metabolism and interactions Nursing pharmacology Personalized medicine Pharmacogenetics and pharmacogenomics Serotonin pharmacology Characterization of drugs and bio-therapeutics Applications of ADME in early drug discovery Rapid methods to assess quality and stability of bio-therapeutics Cholinergic drugs Pharmacokinetics and pharmacodynamics
|Abstracts/Full-Text Paper Submission Deadline||2017-10-10 00:00:00|
|Notification of Acceptance||2017-10-20 00:00:00|
|Final Paper (Camera Ready) Submission &
Early Bird Registration Deadline
|Conference Dates||Dec 04-05, 2017|
Conference Aims and Objectives
The ICCDDP 2017: 19th International Conference on Clinical Drug Developments and Pharmacovigilance aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Clinical Drug Developments and Pharmacovigilance. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Clinical Drug Developments and Pharmacovigilance.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help and shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoritical work in all areas of Clinical Drug Developments and Pharmacovigilance are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials. Federated Conference Federated conference series is an event that brings together significant number of recurring events; academic conferences, symposia, workshops, special sessions, and plenary talks in the field of science and technology since inception in 1999. Each event may run over any span of time within the conference days. Conference Proceedings All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI), Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk. Impact Factor Indicators.
Special Journal Issues
ICCDDP 2017 has teamed up with the Special Journal Issue on Clinical Drug Developments and Pharmacovigilance. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Link :